AMBA
Ambarella, Inc.
AMBA has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
AMBA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
AMBA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AMBA PE Valuation
AMBA has no meaningful PE right now: it lost money over the past year.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
AMBA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for AMBA, with profitability improving. However, they disagree widely on these estimates.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AMBA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.96 | — |
| Q3 2026 | -$1.29 | +$0.82 |
| Q2 2026 | -$1.61 | +$0.88 |
| Q1 2026 | -$1.78 | +$1.06 |
| Q4 2025 | -$1.88 | +$1.99 |
| Q3 2025 | -$2.11 | +$2.22 |
| Q2 2025 | -$2.49 | +$1.78 |
| Q1 2025 | -$2.84 | +$1.41 |
| Q4 2024 | -$3.87 | -$0.85 |
AMBA has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
AMBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $108.1M | +13% |
| Q2 2026 | $100.4M | +17% |
| Q1 2026 | $100.9M | +20% |
| Q4 2025 | $108.5M | +31% |
| Q3 2025 | $95.5M | +50% |
| Q2 2025 | $85.9M | +58% |
| Q1 2025 | $84M | +63% |
| Q4 2024 | $82.7M | +63% |
AMBA's revenue has grown year over year for nine quarters in a row: $108M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.5% | +16 points |
| Q2 2026 | -19% | +11 points |
| Q1 2026 | -18% | +12 points |
| Q4 2025 | -15% | +16 points |
| Q3 2025 | -23% | +34 points |
| Q2 2025 | -30% | +42 points |
| Q1 2025 | -30% | +51 points |
| Q4 2024 | -31% | +52 points |
AMBA has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
AMBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.1M | -612% |
| Q2 2026 | -$29.6M | -389% |
| Q1 2026 | $15M | -30% |
| Q4 2025 | $31.4M | +663% |
| Q3 2025 | $1.4M | -90% |
| Q2 2025 | $10.2M | +$26.3M |
| Q1 2025 | $21.2M | +$27.2M |
| Q4 2024 | $4.1M | -25% |
AMBA has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
AMBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +400K shares |
| 1 year | +3.4% | +1.5M shares |
| 3 years | +11% | +4.3M shares |
| 5 years | +21% | +7.6M shares |
| Available history | +32% | +10.7M shares |
AMBA has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.4M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $1M |
| Q1 2022 | — |
| Q4 2021 | — |
AMBA has spent almost nothing on buybacks in the past year.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
AMBA Net Leverage
AMBA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 16.2 | Oversold |
AMBA's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
AMBA PE vs Technology Sector
AMBA has no meaningful PE right now: it lost money over the past year.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
AMBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.0 | 6% below |
| 20 week MA | $70.1 | 13% below |
| 50 week MA | $67.7 | 9.9% below |
| 100 week MA | $68.1 | 10% below |
| 200 week MA | $65.2 | 6.4% below |
AMBA is in a downtrend: it's below all five of its weekly moving averages, and 6.4% below its 200-week average.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over AMBA on trend strength, trading above more of its moving averages.
AMBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.9 | $92.6 | +55% |
| 2021 | $92.6 | $200.6 | +117% |
| 2022 | $200.6 | $81.2 | -60% |
| 2023 | $81.2 | $61.3 | -25% |
| 2024 | $61.3 | $73.5 | +20% |
| 2025 | $73.5 | $71.4 | -2.9% |
| 2026 YTD | $71.4 | $61.1 | -14% |
AMBA has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.